Systematic Characterization of Recurrent Genomic Alterations in Cyclin-Dependent Kinases Reveals Potential Therapeutic Strategies for Cancer Treatment

Summary: Recurrent copy-number alterations, mutations, and transcript fusions of the genes encoding CDKs/cyclins are characterized in >10,000 tumors. Genomic alterations of CDKs/cyclins are dominantly driven by copy number aberrations. In contrast to cell-cycle-related CDKs/cyclins, which are glo...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Weiwei Shan, Jiao Yuan, Zhongyi Hu, Junjie Jiang, Yueying Wang, Nicki Loo, Lingling Fan, Zhaoqing Tang, Tianli Zhang, Mu Xu, Yutian Pan, Jiaqi Lu, Meixiao Long, Janos L. Tanyi, Kathleen T. Montone, Yi Fan, Xiaowen Hu, Youyou Zhang, Lin Zhang
Format: Artigo
Langue:Inglês
Publié: Elsevier 2020-07-01
Collection:Cell Reports
Sujets:
genomic alteration
cyclin-dependent kinase
cancer
CDK7 inhibitor
PARP inhibitor
combination therapy
Accès en ligne:http://www.sciencedirect.com/science/article/pii/S2211124720308652
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires